Directory → Organotropona funds → The governing bodies of the urinary and reproduction → Dioretiki → Iruzid
This page is translated automatically with a help of Google Translate
IruzidSee also DihydralazineRoman nameIruzidCharacteristicsCombined preparation containing enzyme inhibitor lizinopril and diuretic hydrochlorothiazide.IndicationsEssencialnaya hypertension in patients who have shown a combined therapy.Pregnancy and lactationIs not recommended medication during pregnancy. If pregnancy detected at the time of treatment, admission to the drug as soon as possible to stop except in the case of danger to life Materi.primenenie ACE inhibitors in Groups II and III trimestrah pregnancy can cause damage to the foetus and the newborn (including hypotension, kidney failure, giperkaliemia and / or gipoplaziu skull of the newborn), and death. Oligogidramnion which is likely to be reduced kidney function fruit could lead to contrakturam limbs, blunt head and face, as well as to the development of hypoplastic lungs. Perhaps these side effects do not occur if the embryo subjected to enzyme action in the first quarter Beremennosti.ne to go appoint dioretiki pregnant women with no other health problems, because of his mother and the fetus is a possible risk of newborn jaundice, trombozitopenia and perhaps other side effects, described for Vesroslah.net sufficient data on the allocation of lysinoprile in mother's milk. Tiazidnye dioretiki allocated in the mother's milk. The decision to discontinue treatment or breast-feeding should take into account the possibility of serious side effects in infants, the cause of which may be hydrochlorothiazide and the importance of medication to the mother. If breastfeeding, or if you want to breastfeed a doctor's consultation.ContraindicationsHypersensitivity, incl. other derivative sulfanilamidov, anuria, angineuroticeski swelling, which was related to the treatment of enzyme inhibitor in disorder, hereditary or idiopathic angiootek.Side-EffectsSightings side effects were the same as those described for the treatment of lizinoprilom and gidrohlorotiazidom.Patient interactionProducts potassium kalisberegate dioretiki, salt substitutes containing potassium may lead to increases in concentrations of potassium in serum, especially in patients with compromised renal function (recommended frequent monitoring of potassium in whey). Dioretiki and ACE inhibitors reduce kidney klirens lithium and increase his токсичность.Индомета��ин may reduce the effect antigipertenzivny gidrohlorotiazida Lizinoprila.u and some patients with compromised renal function receiving NPVS, the simultaneous application of ACE inhibitors may lead to a further decline in renal Funktion.tiazidnye dioretiki can increase sensitivity to tubokurarino.Storage conditionsList B. The temperature is not above 25 ° CShelf life2.5 yearsThe registration015463/01 |
All products of this group |